JP Morgan Initiates Intersect ENT With Overweight
August 18, 2014 at 08:45 AM EDT
Analysts at JP Morgan initiated coverage on shares of Intersect ENT (NASDAQ: XENT) with a Overweight rating. The target price for ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.